Jiangsu Libert Inc
SSE:605167
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Libert Inc
SSE:605167
|
CN |
|
Topchoice Medical Co Inc
SSE:600763
|
CN |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
|
KK Seiyoken
TSE:9734
|
JP |
|
LENSAR Inc
NASDAQ:LNSR
|
US |
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
W
|
Whirlpool SA
BOVESPA:WHRL3
|
BR |
|
BCE Inc
TSX:BCE
|
CA |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
M
|
Mooreast Holdings Ltd
SGX:1V3
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Libert Inc's stock price target?
Not Available
Jiangsu Libert Inc doesn't have any price targets made by Wall Street professionals.
What is Jiangsu Libert Inc's Revenue forecast?
Projected CAGR
0%
For the last 5 years the
compound annual growth rate for
Jiangsu Libert Inc's revenue is
20%.
The projected
CAGR
for the next 3 years is
0%.
What is Jiangsu Libert Inc's Operating Income forecast?
Projected CAGR
11%
For the last 5 years the
compound annual growth rate for
Jiangsu Libert Inc's operating income is
18%.
The projected
CAGR
for the next 3 years is
11%.
What is Jiangsu Libert Inc's Net Income forecast?
Projected CAGR
10%
For the last 5 years the
compound annual growth rate for
Jiangsu Libert Inc's net income is
19%.
The projected
CAGR
for the next 3 years is
10%.
